Quote
—
—
We have scored 75 news catalysts on PHR (PHR) over the past 12 months. Coverage across the window leans negative (average ticker sentiment −0.70). Most of the impact sits in price momentum and forward growth expectations.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
No scored news tagged PHR or its network in the window yet.
Show more PHR articles →Analysts publish price targets on PHR, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
9 analyst price targets from $9 to $16
as of 2026-09-10
The market is 14% below the median target — more cautious than the analysts.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about PHR — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for PHR: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The reconstruction
The price sits at the 33rd percentile of published models, rejecting five bull cases to lean bearish, which means it fully assumes the recently announced growth deceleration and resulting legal risk.
What the disagreement turns on
Whether the Network Solutions segment's pharmaceutical advertising revenue is undergoing a temporary pause or a permanent contraction, and the wired data can only measure the resulting volume trend — not the advertiser intent behind it.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
Computed at $10.34 on 2026-09-10 — 59 days ago.
